Segev S - Search Results

1

Post-epidemic serosurvey of West Nile fever in Israel.

Chowers MY, Green MS, Bin H, Weinberger M, Schlaeffer F, Pitlik S, Bishara J, Kaufman Z, Dichtiar R, Mendelson E, Segev S. Chowers MY, et al. Among authors: segev s. Eur J Clin Microbiol Infect Dis. 2005 Dec;24(12):851-3. doi: 10.1007/s10096-005-0061-3. Eur J Clin Microbiol Infect Dis. 2005. PMID: 16362810 No abstract available.

2

Immunosuppressive treatments reduce long-term immunity to smallpox among patients with breast cancer.

Wiser I, Orr N, Kaufman B, Segev S, Smetana Z, Bialik A, Epstein N, Mendelson E, Catane R, Cohen D. Wiser I, et al. Among authors: segev s. J Infect Dis. 2010 May 15;201(10):1527-34. doi: 10.1086/651950. J Infect Dis. 2010. PMID: 20388035

3

Double-blind randomized study of 1 g versus 2 g intravenous ceftriaxone daily in the therapy of community-acquired infections.

Segev S, Raz R, Rubinstein E, Shmuely H, Hassin D, Rosen N, Platau E, Ben Assuli S, Pitlik S. Segev S, et al. Eur J Clin Microbiol Infect Dis. 1995 Oct;14(10):851-5. doi: 10.1007/BF01691490. Eur J Clin Microbiol Infect Dis. 1995. PMID: 8605897 Clinical Trial.

4

Pefloxacin versus ceftazidime in therapy of soft tissue infections in compromised patients.

Segev S, Rosen N, Pitlik SD, Block C, Rubinstein E. Segev S, et al. J Antimicrob Chemother. 1990 Oct;26 Suppl B:193-8. doi: 10.1093/jac/26.suppl_b.193. J Antimicrob Chemother. 1990. PMID: 2258349 Clinical Trial.

5

Ceftizoxime vs. cefotaxime--a comparative randomized multicenter study.

Segev S, Kitzes R, Rubinstein E, Pitlik S, Samra Y, Shenkman L, Weinberg M. Segev S, et al. Isr J Med Sci. 1988 Aug;24(8):410-4. Isr J Med Sci. 1988. PMID: 3045049 Clinical Trial.

6

Safety of long-term therapy with ciprofloxacin: data analysis of controlled clinical trials and review.

Segev S, Yaniv I, Haverstock D, Reinhart H. Segev S, et al. Clin Infect Dis. 1999 Feb;28(2):299-308. doi: 10.1086/515132. Clin Infect Dis. 1999. PMID: 10064248

7

Failure of influenza vaccination in the aged.

Keren G, Segev S, Morag A, Zakay-Rones Z, Barzilai A, Rubinstein E. Keren G, et al. Among authors: segev s. J Med Virol. 1988 May;25(1):85-9. doi: 10.1002/jmv.1890250112. J Med Virol. 1988. PMID: 3411310

8

Impaired fasting glucose and left ventricular diastolic dysfunction in middle-age adults: a retrospective cross-sectional analysis of 2971 subjects.

Milwidsky A, Maor E, Kivity S, Berkovitch A, Zekry SB, Tenenbaum A, Fisman EZ, Erez A, Segev S, Sidi Y, Goldenberg I, Kuperstein R. Milwidsky A, et al. Among authors: segev s. Cardiovasc Diabetol. 2015 Sep 15;14:119. doi: 10.1186/s12933-015-0282-4. Cardiovasc Diabetol. 2015. PMID: 26369690 Free PMC article.

9

Antibiotic cost reduction by providing cost information.

Rubinstein E, Barzilai A, Segev S, Samra Y, Modan M, Dickerman O, Haklai C. Rubinstein E, et al. Among authors: segev s. Eur J Clin Pharmacol. 1988;35(3):269-72. doi: 10.1007/BF00558264. Eur J Clin Pharmacol. 1988. PMID: 3181280

10

Coronary artery calcification is associated with the development of hypertension.

Grossman C, Shemesh J, Dovrish Z, Morag NK, Segev S, Grossman E. Grossman C, et al. Among authors: segev s. Am J Hypertens. 2013 Jan;26(1):13-9. doi: 10.1093/ajh/hps028. Am J Hypertens. 2013. PMID: 23382322

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

106 results

Search Page